ART4 and infection: LNP-encapsulated modified mRNA Ebola virus vaccine, encoding Ebola virus glycoprotein (EBOV GP), delivered IM (Intramuscular), demonstrated stimulated EBOV-specific IgG, neutralizing antibody response, and protection of guinea pigs from infection [94].